| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | May 9, 2025 | NEOGENOMICS INC | Director | Buy | 95.0 | +7,000 | 11.40% | ✗ | $57K |
| Sep 9, 2024 | Sep 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -20,700 | -49.21% | ✓ | $1M |
| Aug 26, 2024 | Aug 28, 2024 | RHYTHM PHARMACEUTICALS, INC. | Director | Sell | 10.0 | -4,300 | -58.90% | ✓ | $215K |
| Aug 12, 2024 | Aug 14, 2024 | RHYTHM PHARMACEUTICALS, INC. | Director | Sell | 7.5 | -10,000 | -76.92% | ✓ | $446.5K |
| Mar 4, 2024 | Mar 6, 2024 | NEOGENOMICS INC | Director | Sell | 22.5 | -6,112 | -10.88% | ✗ | $97.6K |
| Nov 19, 2018 | Nov 21, 2018 | NEOGENOMICS INC | Director | Sell | 22.5 | -13,000 | -25.37% | ✗ | $207.9K |
| Nov 15, 2018 | Nov 16, 2018 | NEOGENOMICS INC | Director | Sell | 22.5 | -5,000 | -8.89% | ✗ | $80.8K |
| Dec 21, 2015 | Dec 23, 2015 | NEOGENOMICS INC | Director | Buy | 95.0 | +9,500 | 187.75% | ✗ | $78K |
| Dec 7, 2015 | Dec 9, 2015 | NEOGENOMICS INC | Director | Buy | 91.3 | +3,500 | 224.36% | ✗ | $27K |